An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Clinical trial NCT01418677 · COMPLETED

Trial details

NCT number

NCT01418677

Sponsor

Eisai Inc.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-10-01

Primary completion

2014-07-01

Enrollment

19

View on ClinicalTrials.gov